 |
 |
Journal articles
Combined TGE-SGE expression of novel PAI-1-resistant t-PA in CHO DG44 cells using orbitally shaking disposable bioreactors.
Abstract : An important modification of thrombolytic agents is resistance to plasminogen activator inhibitor-1 (PAI-1). In previous studies, a new truncated PAI-1-resistant variant was developed based on deletion of the first three domains in t-PA and the substitution of KHRR 128-131 amino acids with AAAA in the truncated t-PA. The novel variant expressed in a static culture system of Chinese Hamster Ovary (CHO) DG44 cells exhibited a higher resistance to PAI-1 when compared with the full-length commercial drug; Actylase. In the present study, the truncatedmutant protein was expressed in CHO DG44 cells in 50 ml orbital shaking bioreactors. The final yield of the truncatedmutant in the culture was 752 IU/ml, representing a 63% increase compared with the static culture system. Therefore, these results suggest that using the combined features of a transient and stable expression system is feasible for the production of novel recombinant proteins in the quantities needed for preclinical studies.
Cited literature [31 references]
https://hal-riip.archives-ouvertes.fr/pasteur-00753540
Contributor : Fatemeh Davami <>
Submitted on : Monday, November 19, 2012 - 1:00:45 PM
Last modification on : Monday, November 4, 2019 - 6:02:03 PM
Document(s) archivé(s) le : Saturday, December 17, 2016 - 12:18:23 PM
Contributor : Fatemeh Davami <>
Submitted on : Monday, November 19, 2012 - 1:00:45 PM
Last modification on : Monday, November 4, 2019 - 6:02:03 PM
Document(s) archivé(s) le : Saturday, December 17, 2016 - 12:18:23 PM
